Article Text

Download PDFPDF
Randomised controlled trial
For proton pump inhibitor-dependent gastro-oesophageal reflux, laparoscopic fundoplication is superior to medical therapy at 5 years of follow-up
  1. David I Watson,
  2. Tim Bright
  1. Flinders University Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia, Australia
  1. Correspondence to : Professor David Watson, Flinders University Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia; david.watson{at}flinders.edu.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text

Context

Gastro-oesophageal reflux disease (GORD) is common in western countries. Up to 40% experience symptoms at least once a month and 10% of adults use proton pump inhibitor (PPI) medication for GORD.1 The REFLUX study addresses a question fundamental to the management of this problem: what is the best treatment strategy? The current study reports 5-year outcomes of a multicentre randomised clinical trial of surgery versus medical management in the UK.

Methods

This randomised controlled trial (RCT) included individuals with objective evidence of GORD who had undergone PPI treatment with reasonable control of GORD symptoms for at least 12 months whom the …

View Full Text

Footnotes

  • Competing interests None.